{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:36:00Z","timestamp":1790242560394,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T00:00:00Z","timestamp":1423440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T00:00:00Z","timestamp":1423440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms6944","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T11:07:12Z","timestamp":1423480032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Activating CAR and \u03b2-catenin induces uncontrolled liver growth and tumorigenesis"],"prefix":"10.1038","volume":"6","author":[{"given":"Bingning","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Seog","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton J.","family":"Finegold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,9]]},"reference":[{"key":"BFncomms6944_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"HB El-Serag","year":"2011","unstructured":"El-Serag, H. B. Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118\u20131127 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms6944_CR2","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/hep.27222","volume":"60","author":"HB El-Serag","year":"2014","unstructured":"El-Serag, H. B. & Kanwal, F. Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? Hepatology 60, 1767\u20131775 (2014).","journal-title":"Hepatology"},{"key":"BFncomms6944_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","volume":"142","author":"BD White","year":"2012","unstructured":"White, B. D., Chien, A. J. & Dawson, D. W. Dysregulation of Wnt\/beta-catenin signaling in gastrointestinal cancers. Gastroenterology 142, 219\u2013232 (2012).","journal-title":"Gastroenterology"},{"key":"BFncomms6944_CR4","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","volume":"95","author":"A de La Coste","year":"1998","unstructured":"de La Coste, A. et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA 95, 8847\u20138851 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6944_CR5","first-page":"1971","volume":"62","author":"N Harada","year":"2002","unstructured":"Harada, N. et al. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin. Cancer Res. 62, 1971\u20131977 (2002).","journal-title":"Cancer Res."},{"key":"BFncomms6944_CR6","first-page":"3245","volume":"61","author":"A Cadoret","year":"2001","unstructured":"Cadoret, A. et al. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res. 61, 3245\u20133249 (2001).","journal-title":"Cancer Res."},{"key":"BFncomms6944_CR7","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/hep.23538","volume":"51","author":"KN Nejak-Bowen","year":"2010","unstructured":"Nejak-Bowen, K. N. et al. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin. Hepatology 51, 1603\u20131613 (2010).","journal-title":"Hepatology"},{"key":"BFncomms6944_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10735-011-9342-6","volume":"42","author":"S Schreiber","year":"2011","unstructured":"Schreiber, S. et al. Phenotype of single hepatocytes expressing an activated version of beta-catenin in liver of transgenic mice. J. Mol. Histol. 42, 393\u2013400 (2011).","journal-title":"J. Mol. Histol."},{"key":"BFncomms6944_CR9","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1093\/emboj\/20.17.4912","volume":"20","author":"A Damalas","year":"2001","unstructured":"Damalas, A., Kahan, S., Shtutman, M., Ben-Ze'ev, A. & Oren, M. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 20, 4912\u20134922 (2001).","journal-title":"EMBO J."},{"key":"BFncomms6944_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature09673","volume":"470","author":"E Elyada","year":"2011","unstructured":"Elyada, E. et al. CKIalpha ablation highlights a critical role for p53 in invasiveness control. Nature 470, 409\u2013413 (2011).","journal-title":"Nature"},{"key":"BFncomms6944_CR11","doi-asserted-by":"publisher","first-page":"e21397","DOI":"10.1371\/journal.pone.0021397","volume":"6","author":"DY Zhang","year":"2011","unstructured":"Zhang, D. Y., Wang, H. J. & Tan, Y. Z. Wnt\/beta-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53\/p21 pathway. PLoS ONE 6, e21397 (2011).","journal-title":"PLoS ONE"},{"key":"BFncomms6944_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1126\/science.1143578","volume":"317","author":"H Liu","year":"2007","unstructured":"Liu, H. et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317, 803\u2013806 (2007).","journal-title":"Science"},{"key":"BFncomms6944_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/hep.20883","volume":"42","author":"A Columbano","year":"2005","unstructured":"Columbano, A. et al. Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology 42, 1118\u20131126 (2005).","journal-title":"Hepatology"},{"key":"BFncomms6944_CR14","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1210\/me.2004-0520","volume":"19","author":"W Huang","year":"2005","unstructured":"Huang, W. et al. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol. Endocrinol. 19, 1646\u20131653 (2005).","journal-title":"Mol. Endocrinol."},{"key":"BFncomms6944_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/carcin\/6.2.225","volume":"6","author":"TA Dragani","year":"1985","unstructured":"Dragani, T. A., Manenti, G., Galliani, G. & Della Porta, G. Promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in mouse hepatocarcinogenesis. Carcinogenesis 6, 225\u2013228 (1985).","journal-title":"Carcinogenesis"},{"key":"BFncomms6944_CR16","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.1158\/0008-5472.CAN-04-1459","volume":"64","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M. & Maronpot, R. R. The orphan nuclear receptor constitutive active\/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 64, 7197\u20137200 (2004).","journal-title":"Cancer Res."},{"key":"BFncomms6944_CR17","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1038\/sj.onc.1204982","volume":"20","author":"H Aydinlik","year":"2001","unstructured":"Aydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A. & Schwarz, M. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 20, 7812\u20137816 (2001).","journal-title":"Oncogene"},{"key":"BFncomms6944_CR18","first-page":"5685","volume":"62","author":"S Loeppen","year":"2002","unstructured":"Loeppen, S. et al. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res. 62, 5685\u20135688 (2002).","journal-title":"Cancer Res."},{"key":"BFncomms6944_CR19","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/carcin\/bgh083","volume":"25","author":"DF Calvisi","year":"2004","unstructured":"Calvisi, D. F., Ladu, S., Factor, V. M. & Thorgeirsson, S. S. Activation of \u03b2-catenin provides proliferative and invasive advantages in c-myc\/TGF-\u03b1 hepatocarcinogenesis promoted by phenobarbital. Carcinogenesis 25, 901\u2013908 (2004).","journal-title":"Carcinogenesis"},{"key":"BFncomms6944_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1124\/dmd.108.026179","volume":"37","author":"A Braeuning","year":"2009","unstructured":"Braeuning, A., Sanna, R., Huelsken, J. & Schwarz, M. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1. Drug Metab. Dispos. 37, 1138\u20131145 (2009).","journal-title":"Drug Metab. Dispos."},{"key":"BFncomms6944_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/toxsci\/kfr166","volume":"123","author":"A Braeuning","year":"2011","unstructured":"Braeuning, A. et al. Gender-specific interplay of signaling through beta-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation. Toxicol. Sci. 123, 113\u2013122 (2011).","journal-title":"Toxicol. Sci."},{"key":"BFncomms6944_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/carcin\/bgq226","volume":"32","author":"B Rignall","year":"2011","unstructured":"Rignall, B., Braeuning, A., Buchmann, A. & Schwarz, M. Tumor formation in liver of conditional beta-catenin-deficient mice exposed to a diethylnitrosamine\/phenobarbital tumor promotion regimen. Carcinogenesis 32, 52\u201357 (2011).","journal-title":"Carcinogenesis"},{"key":"BFncomms6944_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tox.2013.03.019","volume":"308","author":"K Ganzenberg","year":"2013","unstructured":"Ganzenberg, K., Singh, Y. & Braeuning, A. The time point of beta-catenin knockout in hepatocytes determines their response to xenobiotic activation of the constitutive androstane receptor. Toxicology 308, 113\u2013121 (2013).","journal-title":"Toxicology"},{"key":"BFncomms6944_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/0008-5472.CAN-03-2123","volume":"64","author":"N Harada","year":"2004","unstructured":"Harada, N. et al. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res. 64, 48\u201354 (2004).","journal-title":"Cancer Res."},{"key":"BFncomms6944_CR25","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1074\/jbc.M111962200","volume":"277","author":"F Yang","year":"2002","unstructured":"Yang, F. et al. Linking beta-catenin to androgen-signaling pathway. J. Biol. Chem. 277, 11336\u201311344 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6944_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1073\/pnas.1117036108","volume":"109","author":"F Yumoto","year":"2012","unstructured":"Yumoto, F. et al. Structural basis of coactivation of liver receptor homolog-1 by beta-catenin. Proc. Natl Acad. Sci. USA 109, 143\u2013148 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6944_CR27","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","volume":"96","author":"M Shtutman","year":"1999","unstructured":"Shtutman, M. et al. The cyclin D1 gene is a target of the beta-catenin\/LEF-1 pathway. Proc. Natl Acad. Sci. USA 96, 5522\u20135527 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6944_CR28","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"TC He","year":"1998","unstructured":"He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509\u20131512 (1998).","journal-title":"Science"},{"key":"BFncomms6944_CR29","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cell.2012.11.026","volume":"151","author":"J Rosenbluh","year":"2012","unstructured":"Rosenbluh, J. et al. beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151, 1457\u20131473 (2012).","journal-title":"Cell"},{"key":"BFncomms6944_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656\u2013660 (2007).","journal-title":"Nature"},{"key":"BFncomms6944_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1172\/JCI43937","volume":"122","author":"M Anson","year":"2012","unstructured":"Anson, M. et al. Oncogenic beta-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J. Clin. Invest. 122, 586\u2013599 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6944_CR32","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/hep.22475","volume":"48","author":"WE Blanco-Bose","year":"2008","unstructured":"Blanco-Bose, W. E. et al. C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia. Hepatology 48, 1302\u20131311 (2008).","journal-title":"Hepatology"},{"key":"BFncomms6944_CR33","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1038\/onc.2010.47","volume":"29","author":"J Millour","year":"2010","unstructured":"Millour, J. et al. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance. Oncogene 29, 2983\u20132995 (2010).","journal-title":"Oncogene"},{"key":"BFncomms6944_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canlet.2012.09.017","volume":"328","author":"M Katoh","year":"2013","unstructured":"Katoh, M., Igarashi, M., Fukuda, H. & Nakagama, H. Cancer genetics and genomics of human FOX family genes. Cancer Lett. 328, 198\u2013206 (2013).","journal-title":"Cancer Lett."},{"key":"BFncomms6944_CR35","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1101\/gad.1200704","volume":"18","author":"VV Kalinichenko","year":"2004","unstructured":"Kalinichenko, V. V. et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev. 18, 830\u2013850 (2004).","journal-title":"Genes Dev."},{"key":"BFncomms6944_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.canlet.2012.12.008","volume":"331","author":"K Qu","year":"2013","unstructured":"Qu, K. et al. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma. Cancer Lett. 331, 105\u2013114 (2013).","journal-title":"Cancer Lett."},{"key":"BFncomms6944_CR37","doi-asserted-by":"publisher","first-page":"16545","DOI":"10.1074\/jbc.M709604200","volume":"283","author":"SK Li","year":"2008","unstructured":"Li, S. K. et al. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J. Biol. Chem. 283, 16545\u201316553 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6944_CR38","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ccr.2011.10.001","volume":"20","author":"L Anders","year":"2011","unstructured":"Anders, L. et al. A systematic screen for CDK4\/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 20, 620\u2013634 (2011).","journal-title":"Cancer Cell"},{"key":"BFncomms6944_CR39","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1128\/MCB.25.24.10875-10894.2005","volume":"25","author":"IC Wang","year":"2005","unstructured":"Wang, I. C. et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 25, 10875\u201310894 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms6944_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1534-5807(04)00131-5","volume":"6","author":"K Nakayama","year":"2004","unstructured":"Nakayama, K. et al. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev. Cell 6, 661\u2013672 (2004).","journal-title":"Dev. Cell"},{"key":"BFncomms6944_CR41","doi-asserted-by":"publisher","first-page":"25752","DOI":"10.1074\/jbc.M301774200","volume":"278","author":"G Bornstein","year":"2003","unstructured":"Bornstein, G. et al. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278, 25752\u201325757 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6944_CR42","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1091\/mbc.02-02-0023","volume":"13","author":"X Chen","year":"2002","unstructured":"Chen, X. et al. Gene expression patterns in human liver cancers. Mol. Biol. Cell 13, 1929\u20131939 (2002).","journal-title":"Mol. Biol. Cell"},{"key":"BFncomms6944_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0092-8674(02)01015-2","volume":"111","author":"E Batlle","year":"2002","unstructured":"Batlle, E. et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB\/ephrinB. Cell 111, 251\u2013263 (2002).","journal-title":"Cell"},{"key":"BFncomms6944_CR44","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1158\/0008-5472.CAN-06-2344","volume":"67","author":"CA Renard","year":"2007","unstructured":"Renard, C. A. et al. Tbx3 is a downstream target of the Wnt\/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Cancer Res. 67, 901\u2013910 (2007).","journal-title":"Cancer Res."},{"key":"BFncomms6944_CR45","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/j.1349-7006.2009.01284.x","volume":"100","author":"H Miyoshi","year":"2009","unstructured":"Miyoshi, H. et al. Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+\/\u2212 mice. Cancer Sci. 100, 2046\u20132053 (2009).","journal-title":"Cancer Sci."},{"key":"BFncomms6944_CR46","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1177\/0192623308327120","volume":"36","author":"BR Wei","year":"2008","unstructured":"Wei, B. R. et al. Altered \u03b2-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaques. Toxicol. Pathol. 36, 972\u2013980 (2008).","journal-title":"Toxicol. Pathol."},{"key":"BFncomms6944_CR47","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/hep.26924","volume":"59","author":"A Gougelet","year":"2014","unstructured":"Gougelet, A. et al. T-cell factor 4 and beta-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology 59, 2344\u20132357 (2014).","journal-title":"Hepatology"},{"key":"BFncomms6944_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1172\/JCI27527","volume":"117","author":"GA Gusarova","year":"2007","unstructured":"Gusarova, G. A. et al. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J. Clin. Invest. 117, 99\u2013111 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6944_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/aps.2010.4","volume":"31","author":"QF Wu","year":"2010","unstructured":"Wu, Q. F. et al. Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro. Acta Pharmacol. Sin. 31, 361\u2013366 (2010).","journal-title":"Acta Pharmacol. Sin."},{"key":"BFncomms6944_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CEJ.0b013e32836014c8","volume":"23","author":"C La Vecchia","year":"2014","unstructured":"La Vecchia, C. & Negri, E. A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer. Eur. J. Cancer Prev. 23, 1\u20137 (2014).","journal-title":"Eur. J. Cancer Prev."},{"key":"BFncomms6944_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00228-002-0429-6","volume":"58","author":"A Lamminpaa","year":"2002","unstructured":"Lamminpaa, A., Pukkala, E., Teppo, L. & Neuvonen, P. J. Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients. Eur. J. Clin. Pharmacol. 58, 137\u2013141 (2002).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BFncomms6944_CR52","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers, H. & Nusse, R. Wnt\/beta-catenin signaling and disease. Cell 149, 1192\u20131205 (2012).","journal-title":"Cell"},{"key":"BFncomms6944_CR53","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1073\/pnas.1015269108","volume":"108","author":"S Basu","year":"2011","unstructured":"Basu, S. et al. Biology-oriented synthesis of a natural-product inspired oxepane collection yields a small-molecule activator of the Wnt-pathway. Proc. Natl Acad. Sci. USA 108, 6805\u20136810 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6944_CR54","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","volume":"10","author":"L Meijer","year":"2003","unstructured":"Meijer, L. et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem. Biol. 10, 1255\u20131266 (2003).","journal-title":"Chem. Biol."},{"key":"BFncomms6944_CR55","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.biocel.2009.09.001","volume":"43","author":"SP Monga","year":"2011","unstructured":"Monga, S. P. Role of Wnt\/beta-catenin signaling in liver metabolism and cancer. Int. J. Biochem. Cell Biol. 43, 1021\u20131029 (2011).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFncomms6944_CR56","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1038\/sj.onc.1209547","volume":"25","author":"P Laurent-Puig","year":"2006","unstructured":"Laurent-Puig, P. & Zucman-Rossi, J. Genetics of hepatocellular tumors. Oncogene 25, 3778\u20133786 (2006).","journal-title":"Oncogene"},{"key":"BFncomms6944_CR57","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/hep.24813","volume":"55","author":"SM Kim","year":"2012","unstructured":"Kim, S. M. et al. Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology 55, 1443\u20131452 (2012).","journal-title":"Hepatology"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms6944.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6944","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6944.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T12:29:23Z","timestamp":1672921763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms6944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,5,5]]}},"alternative-id":["BFncomms6944"],"URL":"https:\/\/doi.org\/10.1038\/ncomms6944","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,9]]},"assertion":[{"value":"6 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5944"}}